Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

NCT00445146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: EVG
DRUG: RTV
DRUG: ARV regimen

Sponsor

Gilead Sciences